Insider trades
Gilla Kaplan, Director of Avalo Therapeutics AVTX, has filed 0 purchases and 6 sales on the open market. Over the past 12 months that comes to a net sale of $528.5K. The latest trade was on 06/02.
Gilla Kaplan
Director
- Company
- Avalo Therapeutics AVTX
- First filing
- 23/06/02
- Trades
- 25 trades
- Buys / sales
- 0 / 6
- 12-month net buying
- −$528.5K
- Last trade
- 06/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Tyra BiosciencesTYRA | Open-market sale | 03/25 | 03/27 | 14,295 sh | $36.97 | $528,486.15 | −33.6% |
TYRA | Open-market sale | 25/06/17–25/06/18 | 25/06/20 | 9,578 sh2 trades | $9.78avg. | $93,678.54 | −25.3% |
TYRA | Open-market sale | 25/06/12–25/06/16 | 25/06/16 | 51,814 sh3 trades | $10.32avg. | $534,679.32 | −57.8% |
